Masimo Corp Institutional Investor Sentiment Improved in 2018 Q1

June 7, 2018 - By Dolores Ford

Masimo Corporation (NASDAQ:MASI) Logo

Sentiment for Masimo Corp (NASDAQ:MASI)

Masimo Corp (NASDAQ:MASI) institutional sentiment increased to 1.11 in Q1 2018. Its up 0.19, from 0.92 in 2017Q4. The ratio increased, as 143 hedge funds increased and started new holdings, while 129 sold and reduced their equity positions in Masimo Corp. The hedge funds in our partner’s database reported: 41.18 million shares, up from 41.16 million shares in 2017Q4. Also, the number of hedge funds holding Masimo Corp in their top 10 holdings decreased from 1 to 0 for a decrease of 1. Sold All: 38 Reduced: 91 Increased: 90 New Position: 53.

Masimo Corporation, a medical technology company, develops, makes, and markets noninvasive monitoring technologies worldwide. The company has market cap of $5.20 billion. The firm offers Masimo Signal Extraction Technology pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It has a 42.56 P/E ratio. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin saturation; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index.

The stock decreased 1.74% or $1.78 during the last trading session, reaching $100.43. About 135,681 shares traded. Masimo Corporation (NASDAQ:MASI) has risen 13.15% since June 7, 2017 and is uptrending. It has outperformed by 0.58% the S&P500.

Analysts await Masimo Corporation (NASDAQ:MASI) to report earnings on August, 1. They expect $0.72 EPS, down 13.25 % or $0.11 from last year’s $0.83 per share. MASI’s profit will be $37.29 million for 34.87 P/E if the $0.72 EPS becomes a reality. After $0.75 actual EPS reported by Masimo Corporation for the previous quarter, Wall Street now forecasts -4.00 % negative EPS growth.

New Amsterdam Partners Llc Ny holds 1.81% of its portfolio in Masimo Corporation for 94,452 shares. Healthcor Management L.P. owns 575,000 shares or 1.72% of their US portfolio. Moreover, D L Carlson Investment Group Inc has 1.44% invested in the company for 52,106 shares. The Massachusetts-based Redwood Investments Llc has invested 1.36% in the stock. Tributary Capital Management Llc, a Colorado-based fund reported 137,785 shares.

Since January 1, 0001, it had 0 insider buys, and 17 insider sales for $14.97 million activity.

More notable recent Masimo Corporation (NASDAQ:MASI) news were published by: Business.Financialpost.com which released: “New Study Investigates the Utility of Continuous Noninvasive Hemoglobin Measurement With Masimo SpHb® for …” on June 04, 2018, also Seekingalpha.com with their article: “Masimo: Superb Q1, But The Stock Is Too High” published on May 14, 2018, Streetinsider.com published: “Masimo Corp. (MASI) Highlights Data on Utility of Continuous Noninvasive Hemoglobin Measurement With Masimo …” on June 04, 2018. More interesting news about Masimo Corporation (NASDAQ:MASI) were released by: Benzinga.com and their article: “Proctor & Gamble, Mylan And More Stocks Sending Strong Signals This Week” published on May 14, 2018 as well as Ocbj.com‘s news article titled: “Midday Stock Roundup” with publication date: June 01, 2018.

Masimo Corporation (NASDAQ:MASI) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.